Photo from Andres Gomez/Twitter
Aug 29, 2023, 19:15
Andres Gomez: Venetoclax can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.
Andres Gomez, an Associate Professor at Universidad Autónoma de Nuevo León, Mexico, recently tweeted:
“Venetoclax is an expensive life-saving drug in AML. We have proven it can be effectively reduced to 100 mg when combined with azoles in a first-line, phase 2 trial done under limited resources.
Out now in Leuk Res, access here:”
Source: Andres Gomez/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59
Nov 13, 2024, 10:54